Mediation analysis studies situations where an exposure may affect an outcome both directly and indirectly through intervening variables called mediators. It is frequently of interest to test for the effect of the exposure on the outcome, and the standard approach is simply to regress the latter on the former. However, it seems plausible that a more powerful test statistic could be achieved by also incorporating the mediators. This would be useful in cases where the exposure effect size might be small, which for example is common in genomics applications. Previous work has shown that this is indeed possible under complete mediation, where there is no direct effect. In most applications, however, the direct effect is likely nonzero. In this paper we study linear mediation models and find that under certain conditions, power gain is still possible under this incomplete mediation setting for testing the null hypothesis that there is neither a direct nor an indirect effect. We study a class of procedures that can achieve this performance and develop their application to both low- and high-dimensional mediators. We then illustrate their performances in simulations as well as in an analysis using DNA methylation mediators to study the effect of cigarette smoking on gene expression.

Download full-text PDF

Source
http://dx.doi.org/10.1515/ijb-2022-0106DOI Listing

Publication Analysis

Top Keywords

incomplete mediation
8
mediation
5
power testing
4
exposure
4
testing exposure
4
exposure effects
4
effects incomplete
4
mediation mediation
4
mediation analysis
4
analysis studies
4

Similar Publications

Background: Antibodies targeting amyloid beta (Aß) have recently been developed as promising treatments for Alzheimer's Disease (AD). Aducanumab was the first to receive limited FDA approval in 2021 offering much needed new treatment options for AD patients. Aducanumab clears aggregated Aß in the brain, presumably through microglial phagocytosis, although the exact cellular and molecular mechanisms of its effect remain incompletely understood.

View Article and Find Full Text PDF

Heart failure with preserved ejection fraction (HFpEF) is increasingly common but its pathogenesis is poorly understood. The ability to assess genetic and pharmacologic interventions is hampered by the lack of robust preclinical mouse models of HFpEF. We developed a novel "two-hit" model, which combines obesity and insulin resistance with chronic pressure overload to recapitulate clinical features of HFpEF.

View Article and Find Full Text PDF

Large diurnal temperature changes (ΔT) (or the diurnal temperature range (DTR)) in surface soils, ranging from 5°C to often greater than 20°C, are generally acknowledged to occur yet largely disregarded in studies that seek to understand how temperature affects microbially-mediated carbon and nitrogen cycling processes. The soil DTR is globally significant at depths of 30 cm or less, occurring from spring through summer in temperate biomes, during summer periods in the arctic, and year-round in the tropics. Thus, although temperature has long been considered an important factor in controlling microbial processes, our understanding of its effects remains incomplete when considering natural soil temperature cycles.

View Article and Find Full Text PDF

mechanism of action in alveolar bone destruction: Scoping review.

J Indian Soc Periodontol

December 2024

Department of Oral Biology, Faculty of Dentistry, Universitas Indonesia, Jakarta Pusat, Indonesia.

is implicated in periodontitis, a chronic inflammatory disease that destroys the periodontal tissue and alveolar bone due to host-microbe dysbiosis. This study focuses on understanding how contributes to bone destruction in periodontitis. The literature search was conducted using PubMed and Scopus databases based on Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines by entering preselected keyword combinations of inclusion and exclusion criteria.

View Article and Find Full Text PDF

Introduction: Cerebral cavernous malformation (CCM) is a type of cerebrovascular abnormality in the central nervous system linked to both germline and somatic genetic mutations. Recent preclinical and clinical studies have shown that various drugs can effectively reduce the burden of CCM lesions. Despite significant progress, the mechanisms driving CCM remain incompletely understood, and to date, no drugs have been developed that can cure or prevent CCM.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!